Maze Therapeutics, Inc. (MAZE)

CIK 1842295 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Maze Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Nov 4, 202640001676170-26-000026
Nov 2, 20261440001969223-26-001112
Oct 30, 202640002050167-26-000032
Oct 29, 20261440001950047-26-010485
Oct 16, 20268-K0001193125-26-424067
Oct 2, 202640002050172-26-000038
Oct 2, 202640001676170-26-000024
Oct 1, 202640002050167-26-000030
Oct 1, 20261440001969223-26-001044
Oct 1, 20261440001950047-26-009933
Sep 8, 202640002050172-26-000036
Sep 4, 20261440001950047-26-009147
Sep 4, 202640001676170-26-000022
Sep 4, 202640002050167-26-000027
Sep 4, 202640002050172-26-000034
Sep 4, 202640001782758-26-000008
Sep 3, 202640002050167-26-000025
Sep 3, 202640001782758-26-000006
Sep 3, 202640002050172-26-000032
Sep 3, 202640001676170-26-000020
Sep 2, 20261440001782758-26-000005
Sep 2, 20261440001676170-26-000019
Sep 2, 20261440002050167-26-000024
Sep 2, 20261440002050172-26-000031
Sep 1, 20261440001969223-26-000973